LGALS9 and myeloid sarcoma: Blocking the interaction of galectin-9 with Tim-3 results in reduced apoptosis of T cells of RR-MS patients, but not in T cells obtained from PP-MS patients, which may relate to the upregulation of Bat-3 in PP-MS [286].